Vitamin C May Increase the Recovery Rate of Outpatient Cases of SARS-CoV-2 Infection by 70%: Reanalysis of the COVID A to Z Randomized Clinical Trial.

Hemilä, Harri; Carr, Anitra; Chalker, Elizabeth

Hemilä, Harri; Carr, Anitra; Chalker, Elizabeth.

Hemilä H; Department of Public Health, University of Helsinki, Helsinki, Finland.
Carr A; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Chalker E; School of Public Health, University of Sydney, Sydney, NSW, Australia.

Front Immunol ; 12: 674681, 2021.

Article in English | MEDLINE | ID: covidwho-1247866

Subject(s)

Ascorbic Acid/therapeutic use; COVID-19 Drug Treatment; Vitamins/therapeutic use; COVID-19/immunology; Dose-Response Relationship, Drug; Humans; Outpatients; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Zinc/therapeutic use

Keywords

COVID-19; SARS-CoV-2; ascorbic acid; common cold; quantile treatment effect; randomized controlled trials; statistics; treatment outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ascorbic Acid / Vitamins / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.674681

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google